samedan logo
 
 
spacer
home > pmps > summer 2021 > beyond compliance: four steps to best utilise digital pharma inventories
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Beyond Compliance: Four Steps to Best Utilise Digital Pharma Inventories

For decades, using batch numbers was a sufficient means for product identification and traceability in the supply chain. However, as the complexity of supply chains intensify, there is increasing demand for traceability, with stringent national and international regulations being put in place to ensure product authenticity and safety in industries such as pharma, food, and beverage.

In the European pharma industry, through the implementation of the Falsified Medicines Directive (FMD), all actors in the pharma supply chain – including medicine manufacturers, distributors, wholesalers, pharmacies, and hospitals – have had to comply with rigorous traceability standards. The core objectives of which were to increase the security of the manufacturing and delivery of medicines across Europe, protecting patients and preventing falsified medicines from entering the supply chain. For many of these organisations, FMD compliance has involved a significant re-engineering of their processes in order to produce, receive, verify, and decommission serialised medicines.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Since 2015, Sébastien Sliski has been General Manager of Zetes’ Collaborative Supply Chain suite. He was previously the Country Manager of Zetes France, fulfilling several transversal roles for Zetes. Sébastien has more than 15 years of experience in managing supply chain applications in international environments. Before joining Zetes, he was responsible for logistics applications and project management at a corporate level of a French retail group. Sébastien holds a Master 2 degree in Logistics Project Management from The Panthéon Assas University, France.
spacer
Sébastien Sliski
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sartorius to Join the DAX Blue Chip Index

September 4, 2021 – The life science group Sartorius will be admitted to the German DAX blue chip index. After the market closes on September 17, 2021, Sartorius preference shares will be included in the calculation of the DAX, as Deutsche Börse announced on Friday evening.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement